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Abbreviations
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LD50 lethal dose for 50% of the exposed animals at single administration
LOEL lowest observed effect level
NOEL no observed effect level
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11. Introduction
Bronze, an alloy of copper and tin, has been known since 2500 BC. The first
inclusion of tin (Sn) in bronze was probably an accidental result of tin ore being
found in copper ore; pure tin was most likely obtained at a later date (7). For the
first time a workable metal with a low-melting point was available to fabricate
durable weapons, ornaments, coins, cooking utensils, bells and statuary. Mining
and melting became established industries, adjacent cities grew wealthy, the
science of navigation advanced, trade flourished. Tin was mined in Spain, Britain
and Central Europe. This thousand-year-old multifaceted civilisation declined
with the advent of ironmongering.
The second great revolution began in 1810, when tin plate was first used for
canning foods as a result of the military needs of the Napoleonic wars. Five
decades were to elapse before canning of food became prevalent. Concurrently, an
enormous increase in human exposures to tin spread throughout the civilised
world (159).
This document reviews the literature on tin and its inorganic compounds. SnH4
(stannane) is only referred to as a basic compound for the manufacturing of a
large number of organotin compounds and is therefore not included in this
document.
2. Substance identification
Pure tin is a silver-white, shiny metal with the atomic symbol Sn and belongs to
the carbon group (group IVA). Tin’s atomic number is 50 and it has an atomic
weight of 118.71. Tin occurs naturally as the stable isotopes 112Sn (0.97%), 114Sn
(0.65%), 115Sn (0.36%), 116Sn (14.5%), 117Sn (7.7%), 118Sn (24.2%), 119Sn (8.6%),
120Sn (32.6%), 122Sn (4.6%) and 124Sn (5.8%) (43).
The most commercially significant inorganic tin compounds include tin di-and
tetrachloride, tin dioxide, potassium and sodium stannates, tin difluoride, tin
difluoroborate and tin pyrophosphate.
Chemical formulas, molecular weights and CAS numbers of some tin com-
pounds are listed in Table 1.
3. Physical and chemical properties
The melting point (232°C) of pure tin is low compared with those of the common
structural metals, whereas the boiling point (2602°C) exceeds that of most metals
except tungsten and the platinum group. Therefore, loss by volatilisation during
2Table 1. Chemical identification of some tin compounds.
Chemical name Synonyms Chemical
formula
Molecular
 weight
CAS-No
Potassium stannate K2Sn(OH)6 298.9 12125-03-0
Sodium stannate Na2Sn(OH)6 266.7 12209-98-2
Tin Sn 118.7 7440-31-5
Tin(IV) bromide, tin tetrabromide,
stannic bromide
SnBr4 438.3 7789-67-5
Tin(II) chloride, tin dichloride,
stannous chloride
SnCl2 189.6 7772-99-8
Tin(IV) chloride tin tetrachloride,
stannic chloride
SnCl4 260.5 7646-78-8
Tin(IV) chloride iodide tin dichloride diiodide,
stannic dichloride
diiodide
SnCl2I2 443.4 13940-16-4
Tin(II) difluoroborate stannous fluoroborate Sn(BF4)2a 292.3 13814-97-6
Tin(II) fluoride tin difluoride,
stannous fluoride
SnF2 156.7 7783-47-3
Tin(II) iodide tin diiodide,
stannous iodide
SnI2 372.5 10294-70-9
Tin(IV) iodide tin tetraiodide,
stannic iodide
SnI4 626.3 7790-47-8
Tin(IV) oxide tin dioxide,
stannic oxide,
SnO2 150.69 18282-10-5
Tin(II) pyrophosphate stannous pyrophosphate Sn2P2O7 411.32 15578-26-4
Tin(II) sulphate stannous sulphate SnSO4 214.75 7488-55-3
aAvailable only in solution, as the solid form has not been isolated.
melting and alloying with other metals is insignificant. Only small quantities of
some metals can be dissolved in pure liquid tin near its melting point but inter-
metallic compounds are freely formed of which some are of metallurgical
importance. Copper, nickel, silver and gold are appreciably soluble in liquid tin.
Tin coatings can be applied to most metal surfaces by electrodeposition while
molten tin wets and adheres readily to clean iron, steel, copper, and copper-base
alloys. This tin coating provides protection against oxidation of the base metal/
alloy and aids in subsequent fabrication because it is ductile and solderable (114).
3Table 2. Physical and chemical properties of some tin compounds (110).
Compound Melting point
(°C)
Boiling point
(°C)
Density
(g/cm3)
Solubility
in water
Sn 231.9 2602 5.77a
7.27b
insoluble
SnBr4 31 205 3.34 soluble
SnCl2 247 623 3.90 soluble
SnCl4 -33 114 2.23 soluble
SnF2 213 850 4.57 soluble
SnI2 320 714 5.28 slightly soluble
SnI4 143 364.5 4.46 soluble
SnO 1080 6.45 insoluble
SnO2 1630 1900 6.85 insoluble
Sn2P2O7 Decomposes at 400°C 4.01 insoluble
SnS 880 1210 5.08 insoluble
SnSO4 Decomposes at >378°C 
(SO2)
4.15 reacts with
a
 Grey tin, cubic crystalline form.
b
 White tin, silvery tetragonal crystalline form, stable above 13°C.
The II (stannous) and IV (stannic) oxidation states are both reasonably stable
and interconverted by moderately active reagents. The Sn2+/Sn4+ potential is
–0.15V and Sn(II) is well-known as a mild reducing agent. Because of its
amphoteric nature, tin reacts with strong acids and strong bases but remains
relatively resistant to neutral solutions. A thin oxide film forms on tin exposed to
oxygen or dry air at ordinary temperatures; heat accelerates this reaction. Tin is
easily attacked by hydrogen iodide and hydrogen bromide, and less readily by
hydrogen chloride. Hot concentrated sulphuric acid reacts with tin forming tin
disulphate, whereas the diluted acid reacts only slowly with tin at room tempera-
tures. Reaction of tin with dilute nitric acid yields soluble tin nitrates; in concent-
rated nitric acid tin is oxidised to insoluble hydrated tin dioxide. Molten tin reacts
with phosphorous forming a phosphide. Stannates are produced by the action of
strong potassium or sodium hydroxide on tin (114). Physical and chemical
properties of some tin compounds are listed in Table 2.
4. Occurrence, production and use
Tin is found throughout the Earth’s crust at a few parts per million. The average
concentration of particulate tin in air is near 1 ng/m3 in the Northern Hemisphere.
Higher values are observed in the urban atmospheres. The anthropogenic input of
tin into the atmosphere appears to be dominated by emissions from waste
incineration and nonferrous metal production (21).
Tin is mined chiefly as cassiterite (SnO2). The other ores are complex sulphides,
stannite (Cu2FeSnS4), and teallite (PbZnSnS2) (7). The annual world production of
tin has been quite stable at approximately 210 000-230 000 tons for decades, and
out of this 15 000-20 000 tons is secondary metal recovered from scrape waste or
4Table 3. Production of tin, unwroughta. Metric tons. Major tin producing countries (187).
Country 1994 1995 1996
Bolivia 15 539 17 709 16 733
Brazil 20 700 19 800 19 800
China 67 764 67 659 71 500
Indonesia 39 000 44 218 48 960
Malaysia 37 990 39 433 38 051
Thailand  7 634  8 246 10 983
United States 11 700 11 600 11 000
World production 215 598 223 703 229 046
a
 Production of virgin metal (primary) and tin derived from scrap (secondary). Tin alloys are
included.
detinning. The major tin producing countries today are shown in Table 3. In the
Western World, the tin produced is mainly secondary.
Metallic tin is obtained by smelting tin ore. The ore is mixed with salt and
roasted at about 600°C, washed in water and then mixed with anthracite as a
reducing agent and smelted at about 1500°C. After refining the tin is cast into bars
(146, 147).
Because of its resistance to corrosion, tin is used as a protective coating for
other metals. Another important property of tin is its ability to form alloys with
other metals. SnCl4 is used as a dehydrating agent in organic synthesis, a stabiliser
for plastics, and as a chemical intermediate for other tin compounds. SnCl2 serves
as a reducing agent in manufacturing ceramics, glass and inks (85).
Dental amalgams contain varying proportions of tin (12-30%) (11). SnF2 has
been used as a prophylactic agent in preventive dentistry for decades. Sn(II) ions
have a profound and long-lasting inhibiting effect on the oral micro flora in vivo
(4). Topical application of SnF2 appears to provide dentine with a layer of tin and
fluoride, which may provide mechanical and chemical protection and may be of
clinical significance in restorative dentistry. Sn(II) ions possess antibacterial
activity whereas Sn(IV) ions do not (57, 61, 150, 152, 177).
The reducing agent Sn(II) is important in nuclear medicine as an essential
component in diagnostic agents used to visualise blood, heart, lung, kidney and
bone. Sn(II) has nearly ideal redox properties for the reduction of the visualising
label technetium-99m (65, 136, 143).
Most of the operations associated with the extraction of tin ore are wet pro-
cesses, but tin dust and oxide fumes may escape during bagging of concentrate, in
ore rooms and during smelting operations (mixing-plant and furnace tapping), as
well as during the periodic cleaning of bag filters used to remove particulate
matter from smelter furnace flue gas (85).
Tin reclamation from tin plated steel trimmings, rejects from tin-can
manufacturing companies, rejected plating coils from the steel industry, tin
drosses and sludges, solder drosses and sludges, used bronze and bronze rejects
5Table 4. Common uses and sources of exposure to tin and inorganic tin compounds (193).
Substance Use Occupations
Tin metal Tin plating, solder and alloy
production (common alloys are
bronze, brass, gunmetal, bearing
metal, type metal and pewter),
manufacture of food cans
Workers in brass and bronze foundries,
makers of pewter, solder, babbit metal,
and type metal; manufacturers of cans
and metal containers
Inorganic tin
compounds
Manufacture of toothpaste, ceramics,
drill glass, porcelain, enamel, textiles
(used as mordant), and ink
Production workers
and metal type scrap also involve possible exposure to tin dusts and fumes (86).
Common uses and exposures to tin today are shown in Table 4.
Tin production may also involve exposure to silica, lead and arsenic in the
mining of the sulphide ores of tin, and to bismuth and antimony as well in the
roasting and smelting process. Similarly, the preparation and use of tin alloys and
solders present an exposure to these heavy metals. Tin mining may involve
exposure to radon, thorium and uranium (7, 63, 64, 83, 130, 138, 139, 180).
Studies in the United Kingdom showed mean concentrations of Sn in diet of 1-2
mg/kg (60) or approximately 3 mg/day (166). The primary sources of tin were
said to be canned goods (60).
5. Occupational exposure data
Analysis of dust samples collected from tin smelting works (see chapter 11.2.2
and (149)) showed that the dust fraction with particle size < 5 µm in diameter
contained more than 33% of metallic tin and no silica. The concentrations of Sn
(in mg/m3) measured in the workroom air were: check sampling shed 2.22, dracco
(filters for furnace gases) 1.10, smelting furnace man 1.55, refining furnace man
0.82, orehouse skipman 0.34, plumber 0.12, electrician 0.05 and engineer 0.02.
The methods of sampling and analysis were not described (147).
An environmental survey to determine the type of exposure in a Chilean tin
foundry showed air concentrations of metal tin between 8.6 and 14.9 mg/m3 (131).
Tin concentrations in house dust were increased in homes of electric-cable
splicers suggesting that the splicers were contaminating their homes with tin from
work (145).
No systematic data on occupational exposure levels in tin production or
processing are available.
The Norwegian occupational exposure database EXPO contains data from all
samples analysed at the National Institute of Occupational Health in Oslo since
1984. Most of these samples have been collected due to the wish of different
enterprises to control their exposures and are likely to represent "worst case
measurements" (141). Of the 3407 air filters (8-hours personal monitoring)
6Table 5. Branches and job functions in EXPO with air concentrations > 0.05 mg Sn/m3.
Branch/job functions No. of
samples
Mean
(mg Sn/m3)
Range
(mg Sn/m3)
Defence activities/spraying 3 0.20 0.01-0.46
Metal coating/surface coating 2 0.32 0.20-0.45
Electronic production/surface coating 2 1.51 0.09-2.93
Railway repair/termite welding 6 1.07 0.01-5.68
Metal casting/cleaning 2 0.29 0.25-0.34
analysed for tin, 420 contained amounts above the detection limit (0.002 mg
Sn/m3). In Table 5, the branches and job functions with tin levels > 0.05 mg Sn/m3
are listed. If some samples contained > 0.05 mg Sn/m3, all values in the analysis
are included to show the mean and range of concentrations.
6. Measurements and analysis of workplace exposure
When selecting samplers for aerosol collection their sampling characteristics
should comply with internationally accepted sampling criteria (ISO, CEN,
ACGIH). Presently, most measurements are not standardised and do not comply
with these sampling criteria.
The method recommended by NIOSH for measuring airborne inorganic tin and
its compounds, except oxides, is filter acid digestion and atomic absorption or
inductively coupled plasma atomic emission spectrometry. If the aerosol phase is
believed to contain SnO2, the acid solution is centrifuged and the tin compounds
in the supernatant are determined as above. The precipitate is then treated with
alkali, rendering SnO2 to a soluble stannate, and the determination is made as
above (7). Other acid digestion procedures (aqua regia + hydrogen fluoride) are
available for simultaneous measurements of total tin and other elements by e.g.
inductively coupled plasma atomic emission, and mass spectrometry, respectively
(20, 157). Radiochemical neutron activation analysis has been used for the
measurement of tin in human biological materials at background levels (189). A
field portable X-ray fluorescence spectrometer has been developed as a rapid,
nondestructive, on site alternative for analysis of membrane filters used in NIOSH
method 7300 for metals (10).
7. Toxicokinetics
7.1 Uptake
7.1.1 Oral uptake
In vitro experiments on the rat small intestine suggested that absorption of tin
(SnCl4) occurs by passive diffusion. The absorption of SnCl4 was 7.65% after a
single oral dose in rats. The presence of some organic acids resulted in enhanced
absorption of tin from the gastrointestinal tract (98).
7From a single oral dose of 20 mg/kg body weight of radioactive 113Sn(II) or
113Sn(IV) given to 24-hour fasted rats, an absorption of 2.8% and 0.6%, respec-
tively, was estimated. Changing the anion complement from fluoride to citrate had
no effect on the absorption. When the anion was pyrophosphate, the absorption
was lowered. This was explained by the greater tendency of pyrophosphate to
form insoluble complexes with tin (82).
References concerning the absorption of SnCl2 report limited absorption,
usually less than 5% (66, 67, 100, 176).
In rats and cats, no tin was recovered from the urine 24 hours after the ingestion
of orange juice containing high levels of tin (7-20 mg/kg body weight) derived
from containers. 99% of the tin ingested was recovered from the faeces in the rats
indicating a very limited oral uptake (8).
Male Wistar rats were given SnCl2 in their drinking water at three different
concentration levels (0.44, 1.11, 2.22 mM) for 1-18 weeks. The cumulative dose
was 17.7 mmol/kg body weight (corresponding to 2100 mg Sn/kg body weight) in
the highest dose group. Blood tin increased significantly after 1 week at the
highest dose and remained at a level of 16-60 pmol/g (~16-60 nmol/l) or 2-5 times
the concentrations in the control group. In conclusion, despite the fact that
mucosal barrier mechanisms effectively prevent tin absorption they can be over-
come by very high tin doses (155).
Rabbits fed 2 mg SnCl2/kg body weight for 5 days had blood concentrations of
2.3 µg Sn/l (19.4 nmol/l) after 24 hours. After 120 hours the concentration was
0.7 µg/l (5.9 nmol/l). Tin was not detected in the controls (208).
Approximately 50% of the dose was absorbed by man, when 0.11 mg Sn/day
was ingested with the diet (control). From a test diet containing an additional
50 mg Sn/day as SnCl2, only 3% was absorbed (90).
Four human volunteers with Sn blood levels of < 2 ng/ml (17 nmol/l) each
consumed 60 mg Sn in the form of fruit juice from an unlacquered can. Blood
samples were taken after 2, 5 and 24 hours. The 2 females had detectable tin
blood levels of 3 ng/ml (25 nmol/l) only in the 5-hour samples. The 2 males had
peak blood tin concentrations of 4.7 ng/ml (40 nmol/l) after 2 hours, and 3.9
ng/ml (33 nmol/l) after 24 hours, respectively. Remaining blood samples had un-
detectable amounts of tin (22).
Generally, data suggest that the oral uptake of tin is low, but may depend on
dose, anion, and the presence of other substances.
7.1.2 Uptake by inhalation
No valid data on the uptake of inhaled inorganic tin are available.
7.1.3 Skin uptake
No data on the absorption of tin from dermal exposure are available.
87.2 Distribution
7.2.1 Animal data
A single oral dose of 20 mg/kg body weight of radioactive 113Sn(II) or 113Sn(IV) as
fluoride or citrate was given to female Charles River and Cox Charles River rats.
The tissue distribution of tin after 48 hours as a percentage of the administered
Sn(II) or Sn(IV), respectively, was as follows: skeleton 1.0 and 0.24%, liver 0.08
and 0.02% and kidneys 0.09 and 0.02%. Comparing tin in tissues after the 1st and
after the 28th days of oral administration of 20 mg/kg body weight, increased
levels were seen only in bone, and were approximately proportional to the total
amount of systemic exposure. Regarding soft tissues, the authors concluded that
only liver and kidneys are likely to accumulate significant amounts of tin as a
result of the oral ingestion of tin salts. No 113Sn was found deposited in the brains
of rats 48 hours after a single oral dose of 4 mg, after oral daily doses of 20 mg/kg
body weight, 6 days/week for 4 weeks or after a single intravenous dose of 0.4 mg
Sn(II) or Sn(IV) (82). Apparently, the blood-brain barrier for the most part
excludes tin (67, 77, 82, 155).
Studies on the retention of the radionucleide 113Sn administered as SnCl2 intra-
peritoneally in rats showed that most of the tin retained in the body was deposited
in the bone, followed by muscle, pelt, liver and kidney. In contrast to all other
organs, the relative amount of tin (as % of administered 113Sn) in bone increased
considerably (from 50% on day 1 to 65% on day 141) during this experiment (67).
A study of the pharmacodynamics of several tin compounds in rabbits, using
Sn(II) chelates administered with technetium-99m-labelled chelates showed that
free Sn(II) ions localise mainly in bone. The distribution of 113Sn in bone was
similar to that of calcium and other bone-seeking metal ions (49).
Chiba et al reported Sn concentrations in unexposed mice of 0.1-0.29 mg/kg
wet weight, and 0.69 mg/kg dry weight in bone (32).
The concentration of tin in the tibias of rats fed diets supplemented with tin
(> 100 mg Sn/kg diet) were more than 5 times greater than the concentrations in
the kidneys and nearly 20 times greater than the concentrations of tin in the liver.
No other organs were analysed. Tin accumulated in the tibia and kidney in a dose-
dependent manner at ≥ 100 mg/kg diet (92).
After lifelong administration of 0.4 mg Sn/kg body weight/day as SnCl2 in the
drinking water of rats, there was no significant increase in tin concentrations of
examined organs; liver, kidney, heart, lung and spleen. Bone was not examined
(160). In mice, a similar experiment showed tin levels of 1.2-4.5 mg/kg tissue in
kidneys, liver, heart, lung, spleen and thyroid as opposed to less than 0.5 mg/kg in
the control group (158).
A 2-year carcinogenesis study of SnCl2 administered in feed (1000 or 2000 mg
SnCl2/kg) showed a dose-dependent difference in the concentration of tin in
examined organs, i.e bone, liver and kidneys. Tin levels in bone were 9 and
38 mg/kg (low and high dose) in male rats, and 23 and 41 mg/kg, respectively in
female mice. Tin concentrations in the kidneys were 17 and 30 mg/kg in male
rats, and 0.7 and 0.9 mg/kg in female mice. In the liver Sn concentrations were 0.2
9and 0.4 mg/kg (male rats) and 0.4 and 0.5 mg/kg (female mice). Untreated rats
and mice had tin concentrations that were below the detectable limits (124). Dose
estimates in mg/kg body weight are given in chapter 10.4.
Some data indicate that the tin content in the thymus is higher than in other
representative organs. In 4 young adult dogs the tin concentration in thymus was
about twice the concentrations in the spleen or muscle (168). Analysis in un-
exposed adult Lewis rats, adult COBS mice and adult A/KI mice showed thymus
Sn concentrations of 20, 5.5 and 4.3 mg/kg, respectively. Tin concentrated in the
thymus gland as the gland atrophied with age (169).
In pregnant rats fed 20 mg Sn/kg body weight/day as radioactive SnF2 or SnF4,
no tin was found in foetal or placental tissues on the 10th day of pregnancy. Only
small amounts of tin were found in the foetuses on day 21 (82).
In contrast, foetal tin values were elevated (0.8-1.3 mg Sn/kg) in Sprague-
Dawley rats on the 20th day of gestation when the maternal diets contained tin
salts (125 mg-625 mg Sn/kg feed). Untreated rats had foetuses containing 0.64 mg
Sn/kg (182). Assuming a daily feed intake of 20 g/day and a body weight of 250 g
the doses given correspond to 10-50 mg Sn/kg body weight/day.
7.2.2 Human data
With increasing age, tin levels seem to increase in the human lung, possibly
because of inhalation of tin from polluted air. The tin content in human tissues
was high in the United States and low in Africa, and seldom present in newborn
babies in the United States (159).
Hamilton and co-workers determined the Sn content in tissue samples from
adults who had died in accidents and found the highest concentrations in lymph
nodes, lung, liver and kidney (1.5, 0.8, 0.4, 0.2 mg/kg wet weight, respectively),
while levels in muscle and brain were lower (0.07 and 0.06 mg/kg wet weight,
respectively). In bone 4.1 mg/kg ash was reported (76).
Median tin content in adult subjects of the United States in adrenals, lung, liver,
kidney, spleen, muscle, and brain was 5.1, 3.4, 1.8, 1.5, 0.8 and < 0.4, < 0.3 mg/kg
wet weight, respectively (183). In healthy Japanese males, concentrations of 9.8
mg/kg dry weight in hilar lymph nodes and 1.5 mg/kg dry weight in lung tissue
were reported (181).
Chiba et al reported tin concentrations determined by atomic absorption
spectrometry in several human organs. Mean concentrations (mg/kg dry weight,
males, n=11-13) were: liver 1.05, kidney cortex 0.83, heart 0.75, lung 0.45, bone
(rib) 0.61, testis 2.08 (32). The Sn concentration in human liver specimens from
the United States (n=11) ranged from 0.14-0.17 mg/kg wet weight (determined by
neutron activation analysis), and in Japanese human liver specimens (n=23) from
0.08 to 1.12 mg/kg wet weight (determined by atomic absorption spectrophoto-
metry) (27). Sherman et al found that human thymus had an average tin concent-
ration of 12.8 mg Sn/kg wet weight in two children (167).
In unexposed humans, blood tin concentrations of 2-9 µg/l (17-76 nmol/l) are
reported (detection limit 2 µg/l) (76, 97). Corrigan et al found background tin
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concentrations of 11.6±4.4 nmol/l (mean±SD) in plasma and 21.7±6.7 nmol/l in
red blood cells in 12 humans (8 women, 4 men, mean age 77.8 years) (38).
Background concentrations below 1 µg Sn/l (8.4 nmol/l) in serum and urine are
reported (157, 189) and a 95th upper percentile of 20 µg Sn/l (168 nmol/l) in urine
in a group of 496 United States residents (132).
Marked concentrations of Sn were found in the hilar lymph nodes (100 mg/kg
dry weight) and lungs (100 mg/kg dry weight) of one chromate refining worker in
autopsy analysis of the internal organs of 7 metallic workers and 12 unexposed
males in Japan. Elevated concentrations of Sn compared to unexposed were also
observed in lung, spleen, liver and kidney of chromate plating and chromate
refining workers (181).
7.2.3 Conclusion
Inorganic tin distributes mainly to bone but also to the lung, liver, kidney, and
lymph nodes. Some data indicate that tin may have a higher affinity to thymus
than to other organs. Animal data suggest that inorganic tin does not easily pass
the blood-brain barrier.
7.3 Biotransformation
Tin cations are not rapidly reduced or oxidised in the organism (87). Hiles found
that the differences in the relative affinity of the kidneys and liver for Sn(II) and
Sn(IV) indicate a valence stability of the administered tin. He concluded that tin
was not rapidly oxidised or reduced during absorption and systemic transportation
(82).
According to the authors, the marked differences observed between SnCl2 and
SnCl4 in their effects on the immune response in C57BL/6J mice (see chapter
10.7) suggested that these two oxidation states are not readily interconverted in
vivo (50).
7.4 Excretion
7.4.1 Animal data
Absorbed tin is mainly excreted via the kidneys (67, 82, 87, 100, 192).
After a single oral dose of 20 mg/kg body weight of 113Sn(II) or 113Sn(IV) as
fluoride or citrate given to female Charles River and Cox Charles River rats,
approximately 50% of the absorbed tin was excreted within 48 hours. After a
single intravenous dose of 2 mg/kg of 113Sn(II) or 113Sn(IV), 35 and 40%, respec-
tively, was excreted in the urine. 12% of the Sn(II) appeared in the faeces, but
only 3% of the Sn(IV), indicating that the biliary route is more important for
Sn(II) than for Sn(IV) compounds (82).
113Sn was given as SnCl2 orally, intraperitoneally or intravenously to mice, rats,
monkeys and dogs. After parenteral administration, whole-body activities could
be described by 4-component exponential expressions, similar for all species
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studied. Intravenously injected SnCl2 in rats (0.3 µCi/rat) was eliminated with
half-times of 0.4, 4.9, 25 and 90 days (67).
The biological half-time has been estimated to 10-20 days for Sn(II) in rat liver
and kidney. In bone the half-time of Sn(II) and Sn(IV) is approximately 20-100
days (17, 18, 66, 82).
7.4.2 Human data
Eight adult males ate food containing 0.11 mg or 50 mg of Sn/day (as SnCl2).
Their urinary excretion was 29±13 µg (mean±standard deviation) and 122 ±52
µg/day, respectively (90).
In a review article by Magos, it is stated that in humans, 20% of absorbed tin
was cleared with a half-time of 4 days, 20% with 25 days, and 60% with 400
days. No further details are given (111).
8. Biological monitoring
Up to the present very little information is available about tin in human biological
materials even though adequate ultra-sensitive analytical techniques (inductively
coupled plasma mass spectrometry and radiochemical neutron activation) have
been developed for the measurement of tin at background levels (157, 189).
A method of biological monitoring demands knowledge of the relationship
between exposure, external dose, toxicokinetics, internal dose and effects. Such
relationships have not yet been established for inorganic tin and no relevant
methods of biological monitoring are available.
9. Mechanism of toxicity
Even though tin is ubiquitous in animal tissues, no essential function has yet been
shown beyond doubt to be tin-dependent (2, 24, 54, 82, 121, 162-164, 169, 185,
204).
Studies in animals show that inorganic tin interferes with the status of copper,
iron and zinc, which may be due to impaired absorption of these metals (91, 134).
Haem is essential for cell respiration, energy generation and oxidative bio-
transformation. Metal ions directly regulate cellular content of haem and haem
proteins by controlling production of δ-aminolevulinic acid (ALA) syntethase and
haem oxygenase. Thus, metal ions may impair the oxidative function of cells,
particularly those dependent on cytochrome P-450. As a result, the biological
impact of chemicals that are detoxified or metabolically transformed by the P-450
system is greatly altered (55, 112). Chelation of the metal ion into the porphyrin
ring is not necessary in order to regulate the enzymes of haem synthesis and
oxidation (113).
SnF2 and other tin dihalides form complexes with haemoproteins such as
hepatic cytochrome P-450 and haemoglobin (41).
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Substitution of tin for the central iron atom of haem leads to a synthetic haem
analogue (tin(IV)-protoporphyrin) that regulates haem oxygenase in a dual
mechanism, which involves competitive inhibition of the enzyme for the natural
substrate haem and simultaneous enhancement of new enzyme synthesis (51,
154).
SnCl2 (~ 3-30 mg Sn/kg body weight, single subcutaneous dose) and Sn(II)
tartrate (~ 9 mg Sn/kg body weight, single intraperitoneal dose) induce haem
oxygenase in rat liver and kidney (55, 96, 99, 112). The Sn(II) ion is more potent
as an inducer of haem oxygenase-1 in rat cardiac tissue than is the Sn(IV) ion,
administered subcutaneously as tin citrate (single dose, 60 mg/kg of Sn) (119).
Treatment of young spontaneously hypertensive rats with SnCl2 (63 mg/kg
body weight/day of Sn, subcutaneously, twice weekly for 8 or 15 weeks), which
selectively depletes renal cytochrome P-450 through increasing renal haem
oxygenase activity, restores elevated blood pressure to normal (59, 102, 153).
Shargel and Masnyj found that the inhibition of hepatic mixed function oxidase
enzyme activity in Charles River CD albino rats by SnF2 (30 mg Sn/kg body
weight, single intraperitoneal dose) was primarily due to the Sn(II) cation (165).
The activity of δ-aminolevulinic acid dehydratase (ALAD) in the erythrocytes
of Harlan-Sprague-Dawley rats fed 2 g SnCl2/kg diet for 21 days was 55% of that
found in the controls (92). ALAD activity was clearly decreased in Wistar rats
after 2 doses (total 4 mg Sn/kg) of SnCl2 subcutaneously, intraperitoneally or
intragastrically every other day, whereas 7 doses (total 14 mg/kg) resulted in
almost complete enzyme inhibition (206). ALAD was inhibited by SnCl2 but not
by SnCl4. The inhibition was rapidly reversed (28, 30). ALA synthetase and
ALAD were inhibited by tin(II) tartrate (55).
Sn(II) concentrations of 1.5 µmol/l increased the activity of isolated and
purified ALAD from human red blood cells by approximately 30%. At greater
concentrations, tin was an inhibitor of the enzyme, probably due to binding to
allosteric sites (48).
A protective effect of zinc with respect to ALAD activity in blood and ALA
levels in urine was observed after combined administration of SnCl2 and ZnSO4 in
rabbits (33). One subunit of the ALAD enzyme contains one zinc atom and eight
sulphhydryl groups (186). Chiba and Kikuchi postulated that tin attacks one
sulphhydryl group and binds weakly at the zinc-binding site of the enzyme (29).
Injection of selenium (Na2SeO3) intraperitoneally simultaneously with SnCl2 in
ICR mice, completely protects ALAD from being inhibited by Sn. It has been
suggested that selenium protects essential thiol groups in ALAD that are other-
wise blocked by tin (25, 26, 31).
Adverse effects of feeding rats diets containing SnCl2 (100 mg Sn/kg of food)
for 4 weeks include copper depletion and reduction in hepatocellular antioxidant
metalloenzyme activities of superoxide dismutase and glutathione peroxidase.
Impairment in hepatocellular antioxidant protection favours the peroxidation of
fatty acids (144).
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Tin(II) tartrate (20 mg Sn/kg, single intraperitoneal injection) caused a decrease
in glutathione in partially hepatoectomised Sprague-Dawley rats, allowing an
increase in lipid peroxidation damaging the hepatocytic membranes (53). The
inhibitory effect of tin on SH-containing enzymes, particularly hepatic glutathione
reductase and glucose 6-phosphate dehydrogenase, may be caused by the SH-
group forming a metal mercaptide complex with coordinate covalent bonds
leading to decreased catalytic activity. The depression in enzyme levels may also
be due to the interaction of tin with the biological ligands not directly involved in
the active centre of the enzyme but through the formation of an unacceptable
substrate complex for enzyme catalysis (56).
SnCl2 given intravenously in mice resulted in significant inhibition of the P-450
cytochrome dependent hepatic drug metabolising enzymes such as azo-reductase
and aromatic hydroxylase (19).
Pretreatment of mice with SnCl2 (50 mg/kg body weight, daily for 2 days)
induced the coumarin 7-hydroxylase in liver and kidney (58).
SnCl2 (2 mg Sn/kg body weight/day) given orally had inhibitory effects on
calcium content, acid and alkaline phosphatase activity and collagen synthesis in
Wistar rat femoral bone (197-200). SnCl2 orally (60 mg Sn/kg body weight/day
for 3 days) in rats also suppressed insulin secretion and inhibited hepatic phospho-
rylase activity (201, 202), active transport of calcium and mucosal alkaline
phosphatase activity in the duodenum and increased bile calcium contents (195,
203).
SnCl2 exposure caused a dose-dependent increase in the cerebral and muscle
acetylcholinesterase activity in rats given 1.11 and 2.22 mM in drinking water
(highest cumulative dose corresponding to 2100 mg Sn/kg body weight) whereas
no effect was seen at 0.44 mM. The authors concluded that neurochemical effects
of SnCl2 seem to occur only with extreme brain tin burdens and are therefore
probably not relevant (155).
Studies of frog neuromuscular transmission suggest that activation of the
N-type calcium channel is involved in the SnCl2 induced increase in calcium entry
into the nerve terminals (79). SnCl2 itself may facilitate the transmitter release
from nerve terminals in the mammalian (mouse) as well as in the amphibian
(frog) species (80).
An intraperitoneal dose of SnCl2 (5-30 mg Sn/kg) suppressed gastric secretion.
The mechanism of inhibition was assumed to be associated with an inhibition of
nerve transmission as well as reduction of gastrin release from G cells (194, 196).
Corrigan et al reported significant higher plasma and red blood cell Sn con-
centrations in patients with Alzheimer's disease (plasma 21.6 and red blood cells
32 nmol/l) than in those with multiinfarct dementia (12.4 and 19.9 nmol/l) and
controls (11.6 and 21.7 nmol/l) (38, 39). There were negative correlations
between tin levels and the red blood cell polyunsaturated fatty acid levels in the
Alzheimer patients, and the authors suggested that Sn is involved in lipid per-
oxidation in that illness (39).
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In conclusion, tin cations have the ability to influence the biosynthesis and
induce the biodegradation of cytochrome P-450. Some data indicate that Sn(II)
may be more potent in that respect than Sn(IV). In addition, tin seems to have an
inhibitory effect on the activity of several other enzymes. Thus, tin may alter drug
metabolism. An effect of SnCl2 on nerve transmission is reported.
10. Effects in animals and in vitro studies
10.1 Irritation and sensitisation
Solutions of 1% or 2% SnCl2 and 0.25% or 0.5% SnF2 in distilled water on pieces
of gauze were applied to the abraded skin of rabbits for 18 hours. Intraepidermal
pustules with complete destruction of the epidermis were induced. The stratum
corneum remained intact. Sites patch tested with 0.5% SnCl2 or 0.1% SnF2 (water)
showed no pustules but a polymorphonuclear infiltration of leucocytes. When the
solutions were applied to intact skin there was no effect (174).
Larsson et al determined non-irritant levels of SnCl2 and SnCl4 in alcohol on
skin (5%) and on oral mucosa (3% and 0.05% respectively) in Sprague-Dawley
rats. Each test solution was openly applied to the test site for 1 minute, followed 6
hours later by histologic examination of the tissue response. Lesions of allergic
contact type could not be found in the oral rat mucosa (103).
An irritating effect of SnCl2 feeding on the alimentary tract of Wistar rats was
reflected by a diffusely reddened gastric and duodenal mucosa as well as by
mucosal hypertrophy and hyperplasia visible in the entire small bowel at autopsy
(47) (for dose regimen see chapter 10.3).
Janssen et al found ridge-like villi, increased migration of epithelial cells along
the villus, a decreased number of villi per unit surface and increased total length
of the rat small intestine after feeding rats 250 and 500 mg SnCl2/kg diet (88).
Metallic tin was non-toxic in a study using human epithelium-fibroblast co-
culture for assessing mucosal irritancy of metals used in dentistry. Cell viability
and prostaglandin E2 release from the cultures were used as markers for the
irritative potential of the test materials and these markers were not significantly
reduced compared to untreated controls (156).
When guinea-pigs were exposed by inhalation to SnCl4 at 3000 mg/m3 for
10 minutes daily for "several months", only transient irritation of the eyes and
nose developed (133).
10.2 Effects of single exposure
SnCl2 (100 µmol/l) as well as SnO2 (up to 1000 µmol/l) were nontoxic towards
rabbit alveolar macrophages in single-element incubations (101), but there was a
synergistic effect on the depression of superoxide anion radical release in solu-
tions where Sn2+ was combined with Cd2+ or Ni2+ (71).
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Silica containing 97% crystalline SiO2 (50 mg), SnO2 (50 mg) or a mixture of
SnO2-SiO2 (25 mg each in 1 ml saline) dust were instilled intratracheally in rats.
Autopsies were performed on day 10, 20 and 30. The in vivo cytotoxicity (cellular
metabolic activity, lysozyme content and total protein content in rat broncho-
alveolar lavage), interleukin-1 release from rat pulmonary cells and fibrogenic
effects (lung dry weight, collagen content of the whole lung and pathological
grading) after dusting correlated well with the free SiO2 content in the dusts. SnO2
tended to inhibit the effect of SiO2 in the rat lungs. The effects of SnO2 alone were
poorly described (190).
Rats were experimentally exposed to 50 mg of metallic tin dust in saline from a
tin smelting works by a single intratracheal administration. Four months later the
authors described X-ray changes of widespread tiny densities throughout the rat
lungs; changes which they found similar to the X-ray changes earlier seen in
workers exposed to the same compound. Histologically, there was no fibrous
response of any kind up to a year in the rats (146).
Intraperitoneal injections in guinea pigs with dusts from various stages in the
process of a foundry reducing Bolivian tin ore concentrate to metal bars caused
"an inert type of reaction", defined by the authors as dust gathered in flattened
nodules with no change for months, histologically abundant macrophages with
subsequent fibroblastic reaction, and no necrosis (131).
Data on the lethal dose for 50% of the exposed animals at single administration
(LD50) for NaSn2F5 and SnCl2⋅2H2O are given in Table 6. Major toxic symptoms
in rats and mice were ataxia, general depression, fore and hindleg weakness
advancing to flaccid paralysis prior to death. Rats dosed orally developed
diarrhoea. Rats, given either Sn compound, displayed swollen and discolorated
kidneys by autopsy on the 4th day, microscopically tubular necrosis and tubular
regeneration. Further data from this experiment suggest that both F and Sn
contribute to the toxicity of NaSn2F5 (37).
Rats receiving NaSn2F5 (~23 mg Sn/kg) or SnCl2⋅2H2O (~23 mg Sn/kg)
intraperitoneally showed necrosis of the proximal tubules and regeneration of
tubular cells with scar formations, while rats given NaF showed limited focal
lesions (205).
A study by Chmielnicka et al demonstrated a clear derangement of the various
stages in the haem synthesis in rabbits after oral administration of a single dose of
SnCl2. This effect was seen at a dose of 100 mg Sn/kg body weight, but not at
10 mg Sn/kg. A protective effect of zinc with respect to ALAD activity in blood
and ALA levels in urine was observed after the combined administration of tin
and zinc (33).
Male Swiss Webster mice given single intravenous doses of some radio
pharmaceuticals containing SnCl2 as a reducing agent, showed a significant
inhibition of P-450 cytochrome dependent hepatic drug metabolising enzymes
such as azo-reductase and aromatic hydroxylase at a dose level of ~ 0.1 mg Sn/kg
body weight of SnCl2⋅2H2O. The cytochrome P-450 content was also significantly
reduced (19).
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Table 6. 24-hour LD50-data in mice and rats treated with NaSn2F5 or SnCl2⋅2H2O (37).
Species Administration mode LD50
(mg Sn/kg)
NaSn2F5
Rats, male intravenous 9
Rats, female intravenous 9
Mice, male intravenous 13
Rats, male intraperitoneal 50
Rats, female intraperitoneal 43
Mice, male intraperitoneal 54a
Rats, male oral 383
Mice, male oral 396
Rats, male oral (fasted) 149
Rats, female oral (fasted) 146
SnCl2 ·H2O
Rats, male intravenous 15
Rats, male intraperitoneal 136
Rats, male oral 1678
Rats, male oral (fasted) 1197
a 48-hour data given.
Gross and histological examination of various tissues from three species of
animals showed no fibrosis, neoplasia, or other adverse effects following
intravenous administration of SnO2 or Sn particles at high doses. The species,
doses, and times from dosing to examination were: rats 250-1000 mg SnO2/kg,
200-800 mg Sn/kg, 4-26 months; rabbits 250 mg SnO2/kg, 200 mg Sn/kg, 6-26
months; and dogs, similar doses as rabbits, 4-5 years (62).
10.3 Effects of short-term exposure
Weanling Wistar rats were fed diets containing 0, 0.03, 0.10, 0.30 or 1.00% of
various salts or oxides of tin ad libitum for periods of 4 or 13 weeks. End points
examined included mortality, body-weight change, diet utilisation, measurements
of blood, urine and biochemical parameters, organ weights and gross and micro-
pathology. No adverse effects were noted with any levels of Sn(II) oleate, SnS,
SnO or SnO2. Severe growth retardation, decreased food efficiency, slight
anaemia and slight histological changes in the liver were observed with ≥ 0.3%
SnCl2, Sn(II) orthophosphate, sulphate, oxalate and tartrate. The no observed
effect level (NOEL) of tin salts examined was 0.1%, or 22-33 mg Sn/kg body
weight/day, in an unsupplemented diet, which contained a liberal amount of iron
and copper. The authors stated that the level might be lower in diets marginal in
iron and copper. Dietary supplements of iron had a markedly protective effect
against tin-induced anaemia, whereas a decrease in dietary iron aggravated the
condition. The growth depression caused by tin was not alleviated by enriching
the diet with iron and copper (45, 46).
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In rats, ≤ 100 mg Sn/kg diet as SnCl2 (~ 7 mg Sn/kg body weight/day) for 27
days had little effect on the metabolism of copper. Rats fed 500 mg Sn/kg diet
(~39 mg Sn/kg body weight/day) had reduced levels of copper in plasma, liver
and kidneys. Only small changes in iron metabolism were observed. Tin levels of
≥ 500 mg/kg diet were associated with numerous disturbances in the metabolism
of zinc. Moderate variations in dietary zinc levels did not significantly affect the
levels of minerals in tissues (91, 92).
Dietary levels of 100 mg Sn/kg diet in weanling rats for 4 weeks reduced
copper levels significantly in the duodenum, liver, kidney and femur, and zinc
levels in the kidney and femur (140, 144).
Oral administration of SnCl2 (2 mg Sn/kg body weight/day) in rabbits for 1
month decreased zinc and copper concentration in bone marrow and increased
iron concentrations in liver and kidneys (207). Beynen et al found that iron status
(tissue iron, haemoglobin, hematocrit, red blood cell count, plasma iron, total iron
binding capacity and transferrin saturation) in rabbits was not influenced by
dietary tin concentrations < 100 mg Sn/kg diet as SnCl2 for 28 days. Higher
dietary intake of tin caused a decrease in these parameters. Food intake and body
weights were not reported (12).
A study in Wistar rats fed on diets containing various concentrations of tin (1,
10, 50, 100 and 200 mg Sn/kg as SnCl2) for 28 days showed that iron, copper and
zink tissue and plasma concentrations were seemingly unaffected at 1 mg and
slightly decreased at 10 mg Sn/kg diet (~ 0.7 mg Sn/kg body weight/day). Greater
effects were seen at 50 mg/kg diet (~ 3.5 mg Sn/kg body weight/day). The blood
haemoglobin concentration and percentage transferrin saturation decreased in a
linear manner as the level of dietary Sn increased. Analysis of variance and test
for linear trend was used for the statistical evaluation (134).
Growth retardation, slight anaemia, increased relative weights of the kidneys
and liver, irritation of the gastrointestinal tract, "mild" histological changes in the
liver and varying degrees of pancreatic atrophy were observed in Wistar rats fed
SnCl2 for 13 weeks (gradually increased from 163 mg Sn/kg body weight/day in
week 0-4 to 310 mg Sn/kg/day in week 8-13) (47).
Janssen et al investigated the effects of 0, 250 or 500 mg Sn/kg diet (as SnCl2)
in a 4-week study on weanling Wistar rats. Haemoglobin was decreased and body
weights reduced in a dose-related way in the tin-fed groups. Crypt depth, villus
length and cell turnover were increased in parts of the intestine. In week 4, the
estimated doses of tin were about 25 and 50 mg Sn/kg body weight/day, respec-
tively (88).
Oral doses of 2 mg Sn/kg body weight/day as SnCl2 for 5 days did not affect the
process of haem biosynthesis in rabbits. Examined indices were ALAD in whole
blood, liver, kidneys, brain, spleen, and bone marrow, concentrations of free
erythrocyte protoporphyrins, activity of ALA synthetase in the liver and bone
marrow, urine ALA, and co-proporphyrins (208).
In rabbits, a daily oral dose of 10 mg Sn/kg body weight as SnCl2⋅2H2O for
4 months caused transient anaemia in the 6-10th week. A transient high iron
18
serum concentration, a high total iron binding capacity and saturation index were
also observed (34).
A 30-day toxicity study of NaSn2F5 in albino Wistar rats resulted in depressed
growth in a dose-related manner after 15 and 30 days. The daily oral doses of
NaSn2F5 were 20, 100 and 175 mg/kg body weight. Degenerative changes of the
proximal tubular epithelium of the kidneys were observed in 15-20% of the
animals in the groups receiving 175 mg/kg. At 15 days a dose-related decrease in
haemoglobin was found, significant only in males in the two highest dose groups.
Serum glucose levels were decreased at both 15 and 30 days, possibly related to
reduced food intake. The dose of 20 mg/kg (~13.4 mg Sn/kg body weight)
produced only minimal toxicity according to the authors (36).
The distal epiphysis compressive strength decreased significantly in the femoral
bone in Wistar rats administered 300 mg Sn/kg drinking water (as SnCl2) and
laboratory chow contaminated with 52.4 mg Sn/kg of diet for 4 weeks. Feed and
water intake was not reported (127).
The calcium content in the tibia of rats fed 100 mg Sn/kg diet as SnCl2 (~7 mg
Sn/kg body weight/day) for 28 days was decreased (92).
Oral doses of 1.0 mg Sn/kg at 12-hours intervals for 28 days given to male
Wistar rats produced an increase in the Sn content of the femoral diaphysis and
epiphysis, thus resulting in decreased calcium content in bone, and also in
decreased acid and alkaline phosphatase activities in the femoral epiphysis (198).
The dose-effect relationship of oral doses of SnCl2 on biochemical indices in
Wistar rats was studied by Yamaguchi et al. Oral doses of 0.3, 1.0 and 3.0 mg
Sn/kg body weight were given twice daily for 90 days. The 6.0 mg/kg/day dose
caused significant decreases in femur weight, calcium concentration, lactic
dehydrogenase and alkaline phosphatase activities in serum, succinate dehydro-
genase activity in the liver, and calcium content and acid phosphatase activity in
the femoral diaphysis and epiphysis. The 2.0 mg/kg/day dose produced a
significant reduction in succinate dehydrogenase activity in the liver, and the
calcium content and acid phosphatase activity in the femoral diaphysis. At the
0.6 mg/kg/day dose, a slight non-significant decrease in calcium content in the
femoral epiphysis was observed. The results suggested that the LOEL of inorganic
tin orally administered would be 0.6 mg/kg body weight/day (197).
In conclusion, depressed growth, anaemia, a decreased calcium content in bone,
interference with the status of iron, copper and zink, and decreased enzyme
activities are reported in animals after short term administration of some
 
tin
compounds including SnCl2. The anion may influence toxicity.
10.4 Effects of long-term exposure and carcinogenicity
Long Evans rats fed 5 µg Sn/ml (~0.4 mg/kg body weight/day) as SnCl2 in
drinking water from weaning until natural death were compared to an equal
number of controls. Growth was not affected. Significantly lessened longevity
was found in female rats given tin. There were increased incidences of fatty
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degeneration of the liver and of vacuolar changes in the renal tubules in the
animals fed tin. These effects were not observed in Charles River mice. Tin was
not tumorigenic or carcinogenic (158, 160).
From life term studies on the effect of trace elements on spontaneous tumours
in Long-Evans rats it was concluded that the oral ingestion of tin cannot be con-
sidered carcinogenic at the given dose, 5 µg SnCl2/ml drinking water or 0.34-0.38
mg Sn/kg body weight/day. According to the authors this corresponds to approxi-
mately 25 mg of tin daily for a 70-kg man (95).
Stoner et al reported no significant difference in lung tumour production in
strain A mice compared to controls after multiple intraperitoneal injections of
SnCl2 for 30 weeks. Total doses given were 240, 600 and 1200 mg/kg body
weight and the numbers of surviving animals/initial number were 18/20, 12/20,
4/20, respectively (175).
Male and female Fischer F344 rats and B6C3F1 mice received 1000 (low dose)
or 2000 mg (high dose) SnCl2/kg food for 105 weeks. Feed and water were
available ad libitum. Mean body weight gain and feed consumption of dosed and
control rats were comparable. Doses in mg Sn/kg body weight/day are calculated
from feed consumption and body weights for male rats and female mice (Table 7).
Survival appeared to depend on the dose for female mice (controls 38/50, low
dose 33/50, high dose 28/50). For male rats survival rates were 37/50, 39/50,
30/50, respectively. Primary tumours occurring with statistically significant
changes in incidence are summarised in Tables 8 and 9. Such tumours occurred in
male rats and female mice only. C-cell adenomas of the thyroid gland were
significantly increased in low-dose male rats. Thyroid C-cell adenomas and
carcinomas (combined) occurred in male rats with a significant positive trend and
the incidence in either dosed group was significantly higher than seen in the
controls. Adenomas of the lung in male rats occurred with a significant positive
trend. The incidence of female mice with either hepatocellular adenomas or
carcinomas exhibited a significant dose-related trend, and histiocytic lymphomas
in female mice also occurred with a significant positive trend. However,
compared to historic control incidences for this laboratory in about 300 animals,
the tumour incidence was not significantly increased except for male rats at the
low dose.
Lack of dose-response relationship, variable (7-20%) occurrence of these
tumours in untreated animals and no increase in hyperplastic changes in the tin-
treated animals weaken a possible carcinogenic effect of inorganic tin.
Based on this study, SnCl2 given orally in feed was judged by the NTP not to be
carcinogenic for male or female Fischer 344 rats or B6C3F1 mice, although C-cell
tumours of the thyroid gland in male rats may have been associated with the
administration of the chemical (124).
Tin foil imbedded subcutaneously in Wistar rats did not cause any tumour
induction (129).
20
Table 7. Calculated doses in the NTP 105-week study (124).
Species Week Low dose
(mg Sn/kg bw/day)
High dose
(mg Sn/kg bw/day)
Male rats 5 41 89
25 30 68
62 26 55
104 20 35
Female mice 5 182 348
26 134 272
65 92 203
104 137 290
Table 8. Primary tumours in male rats fed SnCl2 in the NTP 105-week study (124).
Male rats Control diet Low dose High dose
C-cell-adenoma (thyroid) 2/50 9/49a 5/50
C-cell-adenoma or carcinoma (thyroid) 2/50 13/49a 8/50a
Lung adenomab 0/50 0/50 3/50
a
 p<0.05, Fisher´s Exact test.
b
 p<0.05, Cochran-Armitage Trend.
Table 9. Primary tumours in female mice fed SnCl2 in the NTP 105-week study (124).
Female mice Control diet Low dose High dose
Hepatocellular adenoma or carcinomab 3/49 4/49 8/49
Histiocytic malignant lymphomab 0/50 0/49 4/49
b
 p<0.05, Cochran-Armitage Trend-
Intracranial implants of metallic tin cylinders in Marsh mice gave a local
response of gliosis, but no fibrous capsules or related neoplasms (13). Intra-
thoracic injection of tin needles in Marsh mice resulted in persisting engulfed
needles by giant cells with some adjacent nodular fibroplasia and a new network
of capillaries. The metal particles were not tumorigenic (14). Intraperitoneal
implantation of tin cylinders led to development of fibrous capsules (15).
The available animal data suggest that metal tin and SnCl2 are not carcinogenic
although one study concludes that C-cell tumours of the thyroid gland in male rats
may have been associated with the administration of SnCl2.
10.5 Mutagenicity and genotoxicity
In the Ames test using various Salmonella strains (TA 1535, TA 100, TA 1538,
TA 98 and TA 1537), SnF2 was slightly mutagenic in strain TA 100, but only in
the presence of a metabolic activation system (S9 liver fraction from Aroclor-
pretreated rats) and on one type of medium (72). SnCl2 tested in the same strains,
with or without the activation system, was not mutagenic in doses of 0.033-10
mg/plate (137).
Kada et al reported the absence of effect (SnCl2, SnCl4 and SnSO4) in the Rec-
assay in Bacillus subtilis, but indicated a high toxic effect of SnCl2 and SnCl4 on
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bacteria (94). SnCl4 tested in the Rec-assay test with Bacillus subtilis in concen-
trations up to 10 mg/test showed no genotoxicity (75).
Strains of Escherichia coli presenting mutations on specific genes for the repair
of DNA were treated with SnCl2 (5-75 µg/ml, corresponding to 26-395 µmol/l).
The results indicate that SnCl2 could be capable of inducing and/or producing
lesions in DNA. This capability was confirmed by the lysogenic induction of E.
coli K 12 and by microscopic observation of E. coli B filamentation (9).
The presence of catalase, reactive oxygen scavengers or metal-ion chelators in
E. coli cultures treated with SnCl2 abolished the lethal effect and suggested the
participation of reactive oxygen species in the toxicological effect of SnCl2 (42).
Survival rates in E. coli were most affected in the strain double mutant on
specific genes for the repair of DNA damage after incubation with SnCl2. Near-
UV illumination inhibited the lethal effect of SnCl2 in E. Coli AB 1157 (wild type
strain) (170).
The SOS chromotest, a simple colorimetric assay of the induction of the
bacterial gene sfiA in E. coli, indicated effects at 2-3 mmol/l of SnCl2, but the
interpretation was difficult because of a clear cyotoxic effect on the bacteria
(128). SnCl4 did not produce DNA-damage in the SOS chromotest (75).
SnCl2 at concentrations of 50, 150, 350 and 500 µmol/l produced dose-related
DNA damage, as detected by alkaline sucrose gradient analysis in Chinese
hamster ovary (CHO) cells. Treatment of cells with Sn(IV) as SnCl4 produced no
such DNA damage. There was no loss in colony formation 6 days after either
treatment (116).
Tin(II) as SnCl2 (5, 10, 25 or 50 µmol/l) was readily taken up by human white
blood cells and caused a dose-dependent increase in DNA strand breaks that was
more extensive than equimolar amounts of chromium(VI), a known carcinogen
and DNA damaging agent. Exposure to tin(II) also interfered with the lympho-
cytes´ ability to be stimulated by the polyvalent mitogen Concanavalin A. Tin(IV)
as SnCl4 did not cause DNA damage and, in contrast to other studies, was not
taken up by cells. The authors state that the relevance of these findings to human
health is not known. The values for tissue bound tin from environmental exposure
are 2-3 orders of magnitude below the levels at which DNA damage was observed
in vitro after an exposure of 30 minutes (115).
SnCl4 at 10 and 20 µg/ml (38-76 µmol/l) increased the frequency of chromo-
somal aberrations, micronuclei and sister chromatide exchanges to a statistically
significant level in human lymphocytes in vitro when compared to the untreated
control. Mitotic index and cell cycle kinetics were depressed. The effects were
directly proportional to the concentrations used (179).
Cultures of human peripheral blood lymphocytes from 27 male donors were
incubated with 2 or 4 µg SnCl4·5 H2O/ml (5.7-11.4 µmol/l) for 70 hours. Both
doses of SnCl4 induced chromosome aberrations in the cells. Approximately 11
and 13% of the cells, respectively, were damaged compared to 4.5% in the control
cultures. Sister chromatid exchanges were about twice as frequent in both tin
cultures compared with controls. A reduction in cell cycle kinetics (replicative
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index) was observed (70). Incubation of human lymphocytes from 52 donors with
SnCl4, 4 µg/ml (11.4 µmol/l, assuming crystallisation water) for 48 hours, resulted
in significant elevations of damaged cells, chromosome aberrations, micronuclei
formation and depression of the mitotic index in both sexes (69).
Intraperitoneal doses of 9.8-39.5 mg SnF2/kg body weight at 0 and 24 hours in
NMRI-mice gave no significant increase in micronucleated polychromatic
erythrocytes from mouse bone marrow. In Drosophila melanogaster fed 1.25 mM
SnF2 in 5% saccharose, no significant increase in sex-linked recessive mutations
was observed (72). SnCl2 was non-genotoxic in the Drosophila wing spot test
(184).
To conclude, in vitro studies have shown that SnCl2 causes DNA damage in
human white blood cells, CHO cells, and in E. coli. The effects on human white
blood cells and CHO cells were dose-dependent. DNA damage in human lympho-
cytes in vitro has been shown after treatment with SnCl4.
10.6 Reproductive and developmental studies
Theuer et al investigated the placental transfer in Sprague-Dawley rats given
various fluorides and tin salts (SnF2, NaSn2F5, NaSn2Cl5) (125 mg-625 mg Sn/kg
feed). Untreated rats had foetuses containing 0.64 mg Sn/kg. Foetal tin values
were found to be elevated (0.8-1.3 mg Sn/kg) when the maternal diets contained
tin salts. The greatest number of foetal resorptions was found in groups fed
sodium pentafluorostannite, but the observation was not considered toxicologi-
cally significant (182).
10.7 Other studies
Intraperitoneal or intravenous injections of metallic tin powder (200 mg in saline)
in Lewis rats produced a striking plasmacellular hyperplasia in the draining lymph
nodes and spleen (106, 108). Depending on the genetic characteristics of the
subjects, the lymph node response to metallic tin in rats varied from a slight banal
response to insoluble foreign particles, to an exuberant granulomatous hyperplasia
(August rats), and intense plasmacellular hyperplasia (Lewis rats and F1 hybrids
of Lewis rats) (105). Pretreatment with tin salts in drinking water prevented the
plasmacellular response to subsequently injected metallic tin as long as 2 months
after the pretreatment (107). The production of plasma cell hyperplasia by
metallic tin and the prevention of such response by tin salts are unique to this
metal (104).
The effect of tin compounds on the immune response to sheep red blood cells in
mice was studied. SnCl2 and SnCl4 (approximately 5 and 3.5 mg Sn/kg body
weight, respectively) intraperitoneally in mice had a number of effects on para-
meters reflecting humoral and cell-mediated immune responses (50).
Subacute administration of SnCl2 (~ 20 mg Sn/kg body weight for 3 days) intra-
peritoneally in mice suppressed parameters of both the primary and secondary
immune response, suggesting that tin supresses part of the immune response in
23
which IgM antibody production is important, and that the IgG production in the
primary response is suppressed or delayed (81).
Jones et al found a significant increase in LD50 values in ICR mice following
intraperitoneal injections of salts of several metal ions including Sn(II) (as SnCl2)
subsequent to pretreatment with the same ion (93).
Intratracheally injected SnCl2 in saline followed by bacterial infection (aero-
solised Group C Streptococcus sp.) increased the mortality with 36 and 87% in
mice at a single dose of 0.01 and 0.1 mg, respectively (~ 6 and 60 µg Sn, corre-
sponding to 0.24 and 2.4 mg Sn/kg body weight). Similar effects were seen with
e.g. fly ashes, carbon, bentonite, and a number of metal oxides. According to the
authors, in the case of soluble metals, inhalation exposure yields similar results
(78).
In conclusion, data imply that tin chlorides have an effect on mouse immune
response. Injections of metallic tin in the rat seem to produce a plasmacellular
hyperplasia in lymph nodes and spleen, an effect that may be prevented by
pretreatment with tin salts.
11. Observations in man
11.1 Effects by contact and systemic distribution
11.1.1 General effects
In 10-11 humans, SnCl2 (36 mg Sn) given with 65ZnCl2 solutions (0.5, 4 and 6 mg
of Zn, respectively) or with turkey test meals (4 mg of 65Zn) inhibited 65Zn absorp-
tion, measured by whole body counting of the retention of 65Zn after 7-10 days.
According to the authors, the dose required to inhibit Zn absorption under the
conditions in this study were well in excess of those ordinarily found in the diet
(188). Solomons et al were unable to demonstrate clear inhibition of the plasma
appearance of zinc after 1- 4 hours in human volunteers ingesting a single dose of
12.5 mg Zn and 25, 50 and 100 mg Sn given as SnCl2 (172).
11.1.2 Skin
Patch tests with metallic tin in 73 nickel-sensitive patients revealed 6 positive
allergic and 4 doubtful reactions. The low frequency of doubtful reactions made it
unlikely that metallic tin is irritant (117).
Patch testing with 1% SnCl2 in petrolatum and a tin disc suggested that some
patients are sensitised to tin. A low frequency of doubtful reactions suggested that
metallic tin and SnCl2 at 1% were non-irritating. However, irritant reactions were
frequent in patients tested with 10% and 5% SnCl2 in petrolatum (44).
In 199 patients with suspected allergic reactions to metals, 13 had positive
patch tests with 2% SnCl2 in petrolatum (26 metals tested) (142).
One out of 50 craftsmen in the ceramics industry had a positive reaction by
patch testing with 2.5% elementary tin in petrolatum (68).
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A worker producing metal patterns for body parts on trucks, exposed to air-
borne dust from an alloy that used to contain tin, had dermatitis around the eyes,
forehead and wrists. He had a positive patch test to 1% SnCl2 in petrolatum. The
case is reported as an occupational allergic dermatitis due to tin (122).
In conclusion, in a few studies positive patch test reactions to metallic tin and
SnCl2 but only one case of occupational allergic dermatitis are reported. Con-
sidering the widespread use of tin and the unclear clinical relevance of the
positive patch test reactions it is unlikely that tin is a contact allergen.
11.1.3 Respiratory system
No clinical or experimental reports on acute effects by inhalation of inorganic tin
have been identified. Metal fume fever caused by inorganic tin has not been
documented (16).
11.1.4 Gastrointestinal tract
Several authors report acute gastrointestinal illness following the intake of canned
fruit or fruit juice.
As a result of the detinning of unlacquered cans by corrosion 200-2000 mg
Sn/kg of food have been reported (23, 73). Estimated doses ingested are 30-200
mg during a short period of time, i.e. drinking a glass of tomato juice (5, 118, 178,
191). Symptoms most frequently reported are nausea, abdominal cramps, vomi-
ting and diarrhoea. Median incubation period was 1 hour (range 15 minutes to 14
hours), and median duration of symptoms 12 hours (range 0.5 hours to 3 weeks)
(5).
Toxic signs (nausea and diarrhoea) followed the drinking of tin-containing fruit
juices by 5 human volunteers only at Sn levels of approximately 1400 mg/l,
corresponding to a single dose of approximately 330 mg or 4.4-6.7 mg/kg body
weight (LOEL) and above. No effects were observed after the ingestion of
approximately 130 mg Sn, or 1.7-2.6 mg Sn/kg (NOEL). The authors stated that
there was no evidence from their experiments that toxicity was due to the
absorption of tin and that the most likely cause was local irritation of the mucous
membranes of the alimentary tract (8).
11.2 Effects of repeated exposure
11.2.1 General effects
Eight adult males were given mixed diets containing 0.11 mg Sn/day (control
diet) and 50 mg Sn/day (test diet, 50 mg of additional Sn as SnCl2 in fruit juice)
for 20 days each in a cross-over design. There was no effect on the faecal and
urinary excretion rates of copper, iron, manganese, magnesium and calcium. Zinc
and selenium excretion rates were moderately changed. Hematocrit and serum
ferritin levels were not affected (74, 89, 90). A mean body weight of 76 kg leads
to an estimated LOEL of 0.7 mg Sn/kg/day in this study.
The uremic patient might be especially prone to accumulate trace elements
from the usual environmental sources. Elevated tin levels have been found in
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muscle, serum, liver and kidney of these patients. As tin affects kidney enzyme
activity in animals (chapter 9), it is suggested that tin might be involved in a
degenerative feedback effect in uremic patients (125, 151).
In a Belgian case-control study (n=272), a significantly increased risk (odds
ratio 3.72, 95% confidence interval 1.22-11.3) of chronic renal failure was found
for occupational exposure to tin. Exposures were scored independently by 3
industrial hygienists (126).
11.2.2 Respiratory system
There are several case reports of workers exposed to SnO2 dust and fumes for 3
years or more in tin smelting works, scrap metal recovery plants and hearth
tinning. The only positive finding is the chest roentgenograms presenting a
pneumoconiosis called stannosis (6, 35, 40, 52, 135, 161, 171, 173). In general, no
information on exposure levels is available.
Dundon and Hughes presented a case report of a "peculiar widespread mottling
of both lung fields by discrete shadows" in the chest roentgenogram in a man who
10 years later died from cancer of the prostate. He had been employed in industry
tending a detinning furnace for 18 years. The employment was terminated 18
years before death. At autopsy, 1100 mg Sn/kg wet weight of lung tissue was
found (52).
Robertson et al examined the employees, including pensioners, from a tin
smelting works and described chest X-ray changes in 121 out of 215 workers. The
changes were widespread, tiny, dense shadows; or softer, larger, more nodular
opacities. Typical changes were found in workers handling raw ore, smelting
furnace house workers and refinery furnace men. The employment time was at
least 3 years, and up to nearly 50 years. None of the men had any clinical
symptoms or signs referable to pneumoconiosis. None of the films suggested
fibrosis or significant emphysema (146, 149). Lung function studies of forced
expiratory volume and airway resistance showed no disability, whatever the
radiographic category. The population at the tin smelting works had lower
mortality (131 deaths) than expected when compared to the male population in the
United Kingdom (expected 166) in the period 1921-55 (147). Dust concentrations
from the tin smelting works were given in chapter 5, e.g. 2.22 mg tin/m3 in the
check sampling shed, but the methods of sampling and analysis were not
described (147).
Autopsy findings were given by Robertson et al for 7 workers with abnormal
radiographs. None had died of pulmonary disease. Aggregates of macrophages
containing dust were seen around respiratory bronchioles and less commonly
around segmental bronchi, in the alveoli, in the interlobular septa and in the
perivascular lymphatics. The mild focal emphysema observed was assumed to be
clinically insignificant and was considerably less severe than that seen in coal
workers pneumoconiosis. No fibrosis was present. Chemical and X-ray diffraction
analysis showed that the lungs contained SnO2. X-ray emission microanalysis
identified tin in a minute particle of dust in lung phagocytes (148).
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Hlebnikova (1957, cited in (87)) made a survey over a number of years of
workers exposed to condensation aerosols formed during the smelting of tin and
consisting mainly of SnO2. Total silica concentration in the aerosols did not
exceed 3%. Total dust concentration in air varied between 3 and 70 mg/m3.
Workers developed pneumoconiosis after 6-8 years of employment. No cases of
pneumoconiosis were observed 10 years after the dust concentration had been
reduced to 10 mg/m3. No further details are given (87).
Symptoms like wheezing, cough, chest pain and dyspnoea on exertion reported
in workers handling SnCl4 were probably due to elevated levels of hydrogen
chloride formed by the combination of SnCl4 and water in the presence of heat
(109).
11.2.3 Conclusion
Occupational exposure to SnO2 dust or fumes induces stannosis with no indication
of fibrosis or apparent disability beyond chest X-ray opacities. An increased risk
of chronic renal failure is reported. Excretion rates of zinc and selenium were
moderately changed in subjects given 0.7 mg Sn/kg body weight/day.
11.3 Genotoxic effects
No data are available.
11.4 Carcinogenic effects
Some reports from China are concerned with the health of tin miners. There were
1724 lung cancer cases registered at the Yunnan Tin Corporation in the period
1954-1986, of which 90% had a history of working underground. Assumed
contributing factors included diet, arsenic, radon and tobacco (63, 138, 139, 180).
Tin was not considered a carcinogenic factor in these studies.
An increased mortality from cancer of the lung was present among Cornish tin
miners. There was a clear relation between exposure to radon and death from lung
cancer (64, 83).
11.5 Reproductive and developmental effects
No data are available.
12. Dose-effect and dose-response relationships
12.1 Single/short-term exposures
12.1.1 In vitro
SnCl2 causes DNA damage in human white blood cells, CHO cells, and in E. coli.
The effects on human white blood cells and CHO cells are dose-dependent. DNA
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damage in human lymphocytes has been shown after treatment in vitro with SnCl4
(115, 116).
12.1.2 Animals
Oral, short-tem studies where the dose is given or possible to estimate are
summarised in table 10.
The LOEL for SnCl2 given orally with respect to calcium content in rat bone, is
~ 0.6 mg Sn/kg body weight/day for 90 days (197). The decrease in calcium
content is dose-dependent.
The LOEL for SnCl2 orally with respect to interference with the status of iron,
copper and zink in rats is ~ 0.7 mg Sn/kg body weight/day for 28 days. Also,
blood haemoglobin levels decrease with increasing Sn levels (0.07-13.2 mg/kg
body weight). Analysis of variance and test for linear trend suggests that there is a
dose-effect relationship for these effects (134).
In mice, an increased susceptiblility to bacterial infection was observed after a
single intratracheal injection of SnCl2 at a dose corresponding to 0.24 mg/kg body
weight (78).
12.1.3 Humans
The NOEL of acute ingestion of SnCl2 with respect to gastrointestinal illness is
approximately 1.7-2.6 mg Sn/kg body weight (8).
The LOEL for SnCl2 administered orally for 20 days with respect to inter-
ference with the excretion of zink and selenium is 0.7 mg Sn/kg body weight/day.
Excretion rates are moderately changed at this level (74, 89, 90).
Positive patch test reactions to tin have been reported (44, 68, 117, 122, 142).
However, only one case of occupational allergic contact dermatitis is published
(122). 5% SnCl2 in petrolatum is irritant, whereas 1% SnCl2 in petrolatum is not
(44). In view of the widespread occurrence of tin, it is probably not a relevant
contact allergen.
12.2 Long-term exposures
12.2.1 Animals
Oral long-term studies where the dose is given or possible to estimate are
summarised in Table 11.
The LOEL for SnCl2 orally in rats in life-long exposures with respect to
degenerative changes in the liver and kidney is ~ 0.4 mg Sn/kg body weight/day
(160).
Available data suggest that metal tin and SnCl2 are not carcinogenic although
one study concludes that C-cell tumours of the thyroid gland in male rats may
have been associated with the administration of SnCl2 (124).
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12.2.2 Humans
Several case reports on inhalation exposure to SnO2 dust or fumes in humans were
found, but systematic data on exposure levels are not available. Exposure time
was 3-50 years. No symptoms or signs of impaired lung function were found, but
there were abnormal findings in radiographs and at autopsy. Aggregates of
macrophages containing dust but no fibrosis were observed (6, 35, 40, 52, 87,
135, 146, 148, 149, 161, 171, 173).
13. Previous evaluations by national and international bodies
The ACGIH and the NIOSH/OSHA recommend an occupational exposue limit of
2 mg/m3 in the interest of minimising the potential of stannosis (1, 123).
In the US Environmental Protection Agency Gene-Tox Program the overall
evaluation placed SnCl2 in the limited negative category for carcinogenicity (120).
SnCl2 was classified as a chemical with equivocal evidence of carcinogenicity
in a review of 301 chemicals tested by the US National Toxicology Program (3).
IARC stated in 1987 that inorganic fluorides used in drinking water, including
SnF2, are not classifiable as to their carcinogenicity to humans (84).
14. Evaluation of human health risks
14.1 Groups at extra risk
Workers with renal disease might be at extra risk of renal effects by exposure to
tin. Johnson et al suggested that chronic exposure of man to moderate levels of tin
in food probably is important mainly to those individuals who chronically
consume low levels of zinc and thus often are in a marginal nutritional status
regarding zinc (the elderly, children and pregnant women).
14.2 Assessment of health risks
14.2.1 Exposure
Occupational exposure to tin and its inorganic compounds is described by
inhalation or skin contact during the handling of tin ore, smelting and industrial
processing of tin. Data on exposure levels are scarce.
Canned food from unlaquered cans may contain high levels of tin.
14.2.2 Effects
Deposition of tin particles in the lungs of exposed workers has been associated to
stannosis, with no indication of fibrosis. No apparent disability beyond X-ray
opacities is found. There are no data on the possible absorption from the lungs.
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Irritant reactions to skin (humans and animals) and mucosa (animals) have been
shown for SnCl4 and SnCl2. Allergic dermatitis in humans has been suggested. No
data on the possibility of skin absorption is available.
When tin is absorbed from the gut it may interfere with the status of other
metals (animals, humans) and/or cause changes in enzyme levels (animals) in
blood, liver, kidney and bone and degenerative changes in liver and kidney
(animals).
SnCl2 was considered not carcinogenic in rats and mice, with the possible
exception of C-cell tumours in the thyroid gland in male rats.
In vitro experiments have shown effects on enzyme activities, and DNA-
damage in human white blood cells, CHO cells and E. coli.
14.2.3 Assessment
The literature on long-term inhalation of inorganic tin consists of case reports in
humans, with poor exposure assessment and old methods of examination. Reports
on effects concerning micropathology and cell toxicity in the respiratory system
are scarce. The information is insufficient to assess the health risk to the lungs.
Tin absorbed from the gastrointestinal tract may affect the mineral status in
animals and humans. On acute ingestion, the irritative symptoms of nausea and
diarrhoea are likely to prevent the ingestion of doses that might represent a further
health risk. For the chronic ingestion during weeks and months, the critical effect
of absorbed tin might be the decrease of calcium content in bone (rats) for short-
time exposures, but interference with the status of minerals is observed at about
the same levels of exposure (0.6-0.7 mg/kg body weight) in both animals and
humans. In older studies, degenerative changes in liver and kidney are observed at
even lower levels (0.4 mg/kg) in life-time exposure in rats. The exact doses of
exposure in mg/kg body weight are difficult to estimate due to the study designs
and lack of information in the reports. The available reports on metallic tin and
SnCl2 are not sufficient to classify tin as a contact allergen.
14.3 Scientific basis for an occupational exposure limit
Data for the concentration of tin in workplace air, in body fluids and organ con-
centrations in workers and toxic effects are scarce. Effects on enzymes and the
concentration of other elements in tissues and fluids are not sufficiently docu-
mented and evaluated for a critical effect to be established. This is also true for in
vitro experiments showing cytogenetic changes in human white blood cells, CHO
cells and E. coli. Although there are some indications that occupational exposures
may cause adverse effects the available data are insufficient for forming a
scientific basis for an occupational exposure limit.
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15. Research needs
Systematic data on occupational exposure levels of inorganic tin in air are needed
as are data on blood or tissue levels in workers exposed to known levels of
inorganic tin in their working atmospheres. There are also few data on back-
ground blood or tissue levels of tin in unexposed humans.
If absorption from occupational exposure is confirmed in the future, further
investigations into the effects on enzymes and mineral status and dose-effect
relationships of inorganic tin on the haematopoietic system, bone, liver and
kidney in humans are necessary. Animal inhalation studies are also lacking.
Data on irritative effects (eye, respiratory tract) are needed. The lung effects
described should be more thoroughly examined by modern laboratories of lung
function, radiology and micropathology. The observed DNA-damage in vitro
should lead to further studies in humans. Further studies according to modern
protocols on carcinogenicity in animals are also needed.
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16. Summary
Westrum B, Thomassen Y. The Nordic Expert Group for Criteria Documentation
of Health Risks from Chemicals and the Dutch Expert Committee on Occupa-
tional Standards. 130. Tin and inorganic tin compounds. Arbete och Hälsa
2002;10:1-48.
Exposure to inorganic tin occurs in the mining and smelting of tin ore, in tin
plating, solder, alloy, toothpaste, ceramics and textile production. Acute gastro-
intestinal illness follows the intake of food containing high levels of tin. Tin
absorption from the gut is < 5%. Tin is deposited in bone, liver, kidneys, and
lymph nodes. Effects of tin are growth retardation, anaemia, changes in enzyme
activities, interactions with the absorption and excretion of calcium, copper, iron
and zinc, and morphological changes in liver and kidney. SnCl2 was considered
not carcinogenic in rats and mice, with the possible exception of C-cell tumours in
the thyroid gland in male rats. Tin chlorides produce DNA-damage in vitro. SnCl2
is irritating to skin. Inhalation of SnO2 may cause X-ray changes (stannosis), but
no apparent pulmonary dysfunction and no fibrosis. Data are insufficient for
identification of a scientific basis for an occupational exposure limit.
Key words: bone, gastrointestinal, kidney, liver, mineral status, occupational
exposure limits, skin, SnCl2, stannosis, tin, toxicity.
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17. Summary in Norwegian
Westrum B, Thomassen Y. The Nordic Expert Group for Criteria Documentation
of Health Risks from Chemicals and the Dutch Expert Committee on Occupa-
tional Standards. 130. Tin and inorganic tin compounds. Arbete och Hälsa
2002;10:1-48.
Eksponering for uorganisk tinn forekommer i tinngruver og smelteverk, i
produksjon av tinnvarer, lodding, legeringer, tannkrem, keramikk og tekstiler.
Inntak av mat med høyt nivå av tinn gir akutt magetarm sykdom. Absorpsjon av
tinn fra tarmen er < 5%. Absorbert tinn blir avsatt i bein, lever, nyre og lymfe-
knuter. Effekter av tinn er veksthemming, anemi, endringer i enzymaktivitet,
interaksjon med absorpsjon og utskillelse av av kalsium, kopper, jern og sink og
morfologiske endringer i lever og nyre. SnCl2 ble vurdert som ikke kreftfrem-
kallende hos rotter og mus, med et mulig unntak for C-celle svulster i skjold-
bruskkjertelen hos hannrotter. Tinnklorider gir DNA-skade in vitro. SnCl2 irriterer
hud. Inhalasjon av tinn kan gi røntgenologiske forandringer (stannose), men
tilsynelatende ingen reduksjon i lungefunksjon og ingen fibrose. Data er
utilstrekkelige for å identifisere et vitenskapelig grunnlag for en grenseverdi for
eksponering i arbeidet.
Nøkkelord: bein, lever, magetarm sykdom, nyre, grenseverdi for eksponering i
arbeid, SnCl2, stannose, tinn, toksisitet.
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19. Data bases used in search of literature
In the search for literature the following data bases were used:
- American Chemical Society
- Arbline
- CISDOC
- HSELINE
- Medline
- NIOSTIC
- RILOSH
- Toxline
Last search was performed in March 2002.
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Appendix 1
Occupational exposure limits for tin and inorganic tin compounds in air.
Country mg/m3 Comments Year Ref
Denmark 2 as Sn 2000 1
Finland 2 as Sn 1998 2
5 as Sn, tin oxide, fume 1998 2
Germany - 2001 3
Iceland 2 as Sn 1999 4
Netherlands 2 as Sn, except SnO2, SnH4 2001 5
2 SnO2
Norway 2 as Sn 2001 6
Sweden - - 2000 7
United Kingdom 2 as Sn, except SnH4 1998 8
4 short-term 1998 8
USA (ACGIH) 2 as Sn, metal 2002 9
as Sn, oxide and inorganic
compounds, except SnH4 2002 9
 (NIOSH) 2 as Sn, except oxides 2000 10
2 as Sn, SnO, SnO2 2000 10
 (OSHA) 2 as Sn, except oxides 2000 10
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